This is the first research in which FSH priming during CEPs of the NS assay is combined with directed differentiation of NSPCs towards the DA pathway by using a defined medium containing SHH, FGF8, and BDNF, a procedure with possible eventual clinical implications for Parkinson’s disease therapy. The gene discussed is FGF8; the disease is Parkinson disease.